Neuralink Reveals Major New Update

🔔 Subscribe now with all notifications on for more Elon Musk news, SpaceX news and Tesla news!

Neuralink, the neurotechnology company founded by Elon Musk, has recently achieved significant milestones in its mission to develop implantable brain-computer interfaces (BCIs). In January 2024, the company successfully implanted its N1 chip into its first human participant, Noland Arbaugh, a 29-year-old who became quadriplegic after a diving accident. This groundbreaking procedure enabled Arbaugh to control digital devices using only his thoughts, allowing him to play video games and browse the internet independently.

Building on this success, Neuralink announced in August 2024 that a second patient, referred to as Alex, received the N1 implant. Alex, who suffered a spinal cord injury, demonstrated remarkable progress by designing 3D objects using CAD software and playing complex video games like Counter-Strike 2, all through mental control. This advancement underscores the potential of Neuralink's technology to restore autonomy to individuals with severe motor impairments.

In addition to these human trials, Neuralink's "Blindsight" device received the FDA's "breakthrough device" designation in September 2024. This experimental implant aims to restore vision by bypassing damaged optic nerves and directly stimulating the visual cortex. Musk highlighted that while initial visual outputs may be low-resolution, future iterations could surpass natural vision and enable perception of infrared and ultraviolet spectra.

These developments mark significant progress in Neuralink's efforts to merge human cognition with advanced technology, offering hope for enhanced quality of life for individuals with neurological challenges.